APA (7th ed.) Citation

AK, M., M, T., N, E., D, E., L, M., K, R., . . . SJ, F. (2026). Does Physician Documentation of Patients' Prostate-Specific Antigen Doubling Time Affect Treatment Decisions in High-Risk Biochemically Recurrent Prostate Cancer? Clinical genitourinary cancer, 24(2), 102496. https://doi.org/10.1016/j.clgc.2025.102496

Chicago Style (17th ed.) Citation

AK, Morgans, et al. "Does Physician Documentation of Patients' Prostate-Specific Antigen Doubling Time Affect Treatment Decisions in High-Risk Biochemically Recurrent Prostate Cancer?" Clinical Genitourinary Cancer 24, no. 2 (2026): 102496. https://doi.org/10.1016/j.clgc.2025.102496.

MLA (9th ed.) Citation

AK, Morgans, et al. "Does Physician Documentation of Patients' Prostate-Specific Antigen Doubling Time Affect Treatment Decisions in High-Risk Biochemically Recurrent Prostate Cancer?" Clinical Genitourinary Cancer, vol. 24, no. 2, 2026, p. 102496, https://doi.org/10.1016/j.clgc.2025.102496.